236 results about "Amniotic liquid" patented technology

The present invention relates to an incubation system for liquid-based incubation of prematurely born infants, comprising: —an inner chamber forming an amniotic basin comprising amniotic fluid, said basin being configured for holding said infant and being made from a flexible material configured for expanding said inner chamber volume in correspondence with the growth of said infant; —an outer chamber enclosing said inner chamber and comprising a temperature regulation fluid, —a fetal connection port, arranged for connecting with the umbilical cord of said infant, said umbilical cord providing a port in said inner chamber to said infant for providing dialyzation and nutrition compounds to said infant via said umbilical cord; —a fetal control unit, connected to said fetal connection port for control of said dialyzation and control of said provided nutrition by monitoring and controlling one or more of a pressure, flow and temperature thereof; an amniotic fluid circulation unit, arranged for connecting with an inlet / outlet port of said inner chamber and comprising a pump for circulating said amniotic fluid from said inner chamber and through a purification system located outside said inner chamber; and —a temperature regulation fluid control unit, arranged for connecting with an inlet / outlet port of said outer chamber and comprising a pump for circulating said temperature regulation fluid from said outer chamber and through a heat exchanger system located outside said inner chamber.

The invention discloses a blue light device for treating child jaundice, and particularly relates to the technical field of child jaundice treatment.The blue light device comprises a bottom frame and a treatment box installed on the bottom frame, a baby crib and a blue light irradiation part are arranged in the treatment box, and a shaking mechanism for driving the baby crib to shake in a reciprocating mode is further arranged on the bottom frame; the baby bed is provided with a treatment cavity for treating a baby, and a fixed bed plate and a movable bed plate capable of being rotationally adjusted are arranged in the treatment cavity; through the arrangement of the fixed bed plate and the movable bed plate capable of being rotationally adjusted, the body of the newborn can be inclined through the adjusting component, the situation of milk regurgitation or amniotic fluid regurgitation of the newborn is relieved, and the newborn is prevented from crying due to improper milk regurgitation or amniotic fluid regurgitation and the like, so that the newborn can be prevented from crying and twisting, and the health of the newborn is protected. In addition, jaundice treatment of the neonates is facilitated, and the treatment efficiency is improved.

The invention discloses an amniotic fluid sourced lactobacillus crispatus and application thereof. The lactobacillus crispatus is preserved in the China General Microbiological Culture Collection Center on July 3, 2024, and the preservation number of the lactobacillus crispatus is CGMCC (China General Microbiological Culture Collection Center) No.31148. The lactobacillus crispatus has the advantages that the lactobacillus crispatus is preserved in the China General Microbiological Culture Collection Center on July 3, 2024; the new lactobacillus crispatus strain obtained through screening comes from amniotic fluid, can effectively remove free radicals, is high in oxidation resistance, hydrophobicity and self-aggregation capacity and can adhere to and be planted in a living body, and a product developed by utilizing the new strain has the effects of regulating gastrointestinal flora and resisting oxidation and is wide in application prospect.

The invention provides a multimodal data fusion analysis method and system for pregnant and birth health. The method comprises the following steps: acquiring enhanced Raman spectrum data of amniotic fluid of a pregnant woman and electrical impedance spectrum data of blood of the pregnant woman; extracting a half-peak width parameter and a displacement parameter of a characteristic peak in a preset range from the enhanced Raman spectrum data, and analyzing a dielectric relaxation frequency variation parameter of a preset frequency band from the electrical impedance spectrum data; performing correlation analysis on the half-peak width parameter, the displacement parameter and the dielectric relaxation frequency variation parameter to construct a multi-dimensional interaction parameter; performing multi-modal data fusion analysis on the multi-dimensional interaction parameters to obtain a multi-modal data fusion analysis result including an amniotic fluid embolism probability value so as to realize risk early warning of amniotic fluid embolism; according to the multi-modal dynamic coupling and cross-scale pathological modeling, the technical barriers of data dimension limitation, static analysis lagging and multi-modal data isolation in the prior art are overcome, and an innovative technical path is provided for early accurate early warning of amniotic fluid embolism.

The multifunctional female detection protection pad comprises a protection pad body, at least two detection chips capable of developing colors and a colorimetric card, the upper surface of the protection pad body is provided with a surface layer, the two detection chips are fixed to the surface layer, one detection chip is located on the front side of the middle of the surface layer, and the other detection chip is located on the front side of the middle of the surface layer. The other detection chip is located on the rear side of the middle of the surface layer, protection wings are arranged on the two sides of the middle of the protection pad body, and the colorimetric cards are arranged on the protection wings. The two detection chips capable of developing are arranged on the surface layer of the multifunctional female detection protection pad, and whether gynecological inflammation or early rupture of amniotic fluid exists or not is judged by detecting liquid in the vagina and developing of the detection chips. After the color development reaction occurs, further confirmation is carried out by comparing with the colorimetric cards arranged on the protective wings, so that the gynecological inflammation or the early rupture of amniotic fluid can be found as soon as possible, and the worsening of diseases caused by the fact that the gynecological inflammation or the early rupture of amniotic fluid cannot be found in time is avoided.

A multi-part processed human amniotic composition configured to treat Peyronie's disease in a subject in need thereof by intracorporeal injection of the composition into the corpus cavernosum of the subject to reduce plaque size associated with Peyronie's disease. The multi-part processed human amniotic composition includes a micronized human amnion composition; and an aqueous human amniotic fluid filtrate configured to reconstitute and suspend the micronized human amnion composition therein. In certain aspects, the multi-part processed human amniotic compositions are not processed with exogenous enzymes during production thereof and do not include exogenous enzymes, such as collagenase, added thereto.

The present invention discloses a method for synchronously extracting and detecting 59 endocrine disruptors in amniotic fluid, belonging to the technical field of substance detection. The method includes the following steps: S1, adding β-glucuronidase to the amniotic fluid sample and incubating; S2, adding a stable isotope-labeled internal standard to the amniotic fluid sample to be detected in step S1; S3, adding the amniotic fluid sample to be detected in step S2 to an activated HLB extraction column to remove impurities and extract the target analyte; S4, eluting the extraction column to obtain an eluate, blowing it to near dryness, and adding a reconstitution solvent to obtain a sample to be detected; S5, using a liquid chromatography-mass spectrometry instrument to detect the sample to be detected obtained in step S4 to complete the detection and analysis of endocrine disruptors. The detection process is carried out simultaneously in positive ion mode and negative ion mode. This method realizes the synchronous extraction, detection and analysis of at least 59 typical environmental endocrine disruptors in amniotic fluid, which is simple and convenient, and solves the problems of large sample consumption and long time consumption.

The utility model belongs to the technical field of membrane rupturing devices, and particularly relates to an amniotic membrane rupturing device for gynaecology and obstetrics, which comprises a handle, one end of the handle is fixedly connected with a membrane rupturing hook, and the membrane rupturing hook is arranged towards the other end of the handle; the front face and the back face of the handle are each provided with a liquid guide groove formed in the length direction of the handle, the handle is provided with penetrating holes corresponding to the liquid guide grooves, and the penetrating holes are all formed in the ends, away from the membrane breaking hooks, of the liquid guide grooves. A handheld part is arranged at one end, far away from the membrane rupture hook, of the handle, and an annular groove is further formed in the handle and is formed between the handheld part and the liquid guide groove; the utility model provides the amniotic membrane rupture device for the obstetrics and gynecology department, which can be used for guiding amniotic fluid.

The utility model provides an artificial membrane rupture device, which relates to the technical field of assistive devices and comprises a tube body, an adjusting block is arranged on one side of the tube body, a rotating ring is arranged in the middle of the adjusting block, an adjusting component is arranged on the inner ring of the rotating ring, a pressing block is arranged at one end of the tube body, a group of discs are arranged at the bottom of the pressing block, and the disc is arranged on the other end of the tube body. A set of sliding grooves are formed in the inner wall of the pipe body, sliding blocks are arranged in the sliding grooves, the sliding blocks are connected with discs, a jacking assembly is arranged between the discs, and an opening assembly is arranged at the other end of the pipe body. The device solves the problems that the depth of a needle head is inconvenient to control by holding the needle head during manual membrane rupture, a membrane rupture opening is inconvenient to expand after membrane rupture, and amniotic fluid is inconvenient to collect.

The invention discloses an amniotic fluid drainage device for an operating room. The amniotic fluid drainage device comprises a drainage box and a fixing cylinder. A drainage tube is arranged at the upper end of the drainage box and movably connected with the fixing cylinder; the interior of the fixing cylinder is hollow, the upper end is provided with a fixing ring, two sides are symmetrically provided with depth sliding grooves which are slidably connected with fixing rods, a plurality of fixing grooves are arranged along one side of each depth sliding groove in an array mode, the other side is provided with scales, and two sides of the bottom are symmetrically provided with fixing pieces. The middle of the fixing rod is provided with a limiting ring rotationally connected with the needle handle; the front end of the needle handle is provided with the needle body, and the rear end is provided with the hard tube slidably connected with the fixing ring. The hard tube penetrates through the fixed cylinder and is provided with a drainage tube which is movably connected with the drainage box; through sliding fit of the fixing rod and the depth sliding groove, the height of the fixing rod in the fixing cylinder can be visually adjusted along the scales, and precise control over the insertion depth of the puncture needle is achieved in combination with rotary connection of the limiting ring and the needle handle.

The invention relates to a new application of early-stage chick embryo amniotic fluid, which is characterized in that the early-stage chick embryo amniotic fluid is found to be capable of effectively dispelling the effects of alcohol, removing the content of ethanol in serum and increasing the levels of liver acetaldehyde dehydrogenase and ethanol dehydrogenase by evaluating the effect of dispelling the effects of alcohol of the early-stage chick embryo amniotic fluid, and also has the effects of protecting the gastric mucosa function and the like.

Homogeneous human amniotic fluid stem cell clones are provided. The clones serve as direct bioassays to test the effect of drugs, nutraceuticals, vitamins and toxic agents on fetus growth, differentiation and development, and may be administered in form of pharmaceutical compositions for reconstructive engineering and for the treatment of cardiac, neurological and osteoarthritic diseases.

The invention relates to the technical field of medicines, in particular to application of sialic acid in preparation of a medicine for promoting stem cell migration, the administration concentration of the sialic acid is 0.625 mM to 5mM, the sialic acid (SA) has the influence on proliferation and migration of amniotic fluid mesenchymal stem cells (AFMSCs), the sialic acid with the concentration of 0.625 mM, 1.25 mM, 2.5 mM and 5mM is used for experiments, and results show that the sialic acid with the concentration of 0.625 mM, 1.25 mM, 2.5 mM and 5mM has the influence on the proliferation and migration of the AFMSCs. The migration of the amniotic fluid mesenchymal stem cells is promoted, and the migration rate of the AFMSCs is 100% due to the SA with the concentration of 1.25 mM, 2.5 mM and 5 mM in 48 hours.

The utility model discloses a degradable amniotic fluid absorption pad which comprises an outer groove pad and an inner water absorption pad, the outer groove pad is a degradable waterproof groove pad, the inner water absorption pad is a degradable water absorption pad, a waterproof coating is arranged on the outer wall of the outer groove pad, the bottom of the inner water absorption pad is bonded to the groove bottom of the outer groove pad through a bonding layer, a plurality of water inlet grooves are formed in the inner water absorption pad, and the water inlet grooves are communicated with the water inlet grooves. Water absorption holes are formed in the side wall of the water inlet groove, the outer groove pad is made of poly (butylene succinate), the inner water absorption pad is made of polylactic acid non-woven fabric, poly (butylene succinate) and poly (butylene succinate) are both degradable materials, and the inner water absorption pad is torn off to be separated from the outer groove pad after use, so that the thickness can be reduced, and the degradation speed can be increased; during use, amniotic fluid of a pregnant woman is absorbed through the inner water absorption pad, meanwhile, the amniotic fluid is prevented from seeping out of the outer groove pad, the contact area of the inner water absorption pad and the amniotic fluid can be increased through the arrangement of the water inlet groove and the water absorption holes, and the effects of shunting, delaying flowing, accelerating amniotic fluid absorption and rapidly absorbing the amniotic fluid are achieved.

The invention relates to the technical field of medical tools, in particular to an artificial membrane rupturing structure which comprises a barrel and a suction cup mounted at the top end of the barrel and further comprises a guide seat, a membrane rupturing device, a membrane rupturing device and a membrane rupturing device, the guide seat is mounted in the barrel, and a through hole is formed in the guide seat; the adsorption mechanism is installed in the cylinder body and connected with the guide seat, and the adsorption mechanism enables the suction cup to be adsorbed to the surface of the amniotic membrane; the artificial membrane rupturing structure is different from the prior art, in the using process of medical staff, the amniotic membrane can be clamped and fixed only by attaching the suction cup to the amniotic membrane and then pulling the hollow push rod, then puncturing is automatically conducted, the flow speed after membrane rupturing is stable, the membrane rupturing can be easily completed even though the medical staff with less experience, and operation is easy; the amniotic fluid after rupture of the membrane automatically flows to the outside through the drainage tube from the inside of the cylinder, and the amniotic fluid is not in contact with the uterus of the pregnant woman, so that the probability of infection in the uterus of the pregnant woman is greatly reduced, and the turbidity of the amniotic fluid flowing out can be directly observed.

The utility model discloses a visualized amniotic fluid puncture outfit relates to medical instrument technical field, including superfine endoscope and puncture component, the puncture component includes T-type drainage tube, the both sides of T-type drainage tube are provided with drainage connection port, the drainage connection port is controlled by flow valve, and the drainage connection port is connected with the flow valve. A puncture needle tube is arranged at the bottom of the T-shaped drainage tube, the top of the T-shaped drainage tube is connected with a superfine endoscope through a connecting fastener, a superfine endoscope lens is arranged at the bottom of the superfine endoscope, and the superfine endoscope lens is inserted into the puncture needle tube. According to the amniotic fluid puncture needle, a doctor can directly perform puncture operation, the risk of accidentally injuring tissues of a fetus and a maternal body is remarkably reduced, the position of the needle head and the puncture depth can be more accurately judged, and the efficiency of amniotic fluid puncture is improved.

The utility model discloses a blood separator based on puerpera bleeding detection. The blood separator comprises a shell, the upper part of the shell is provided with circular groove bodies which are symmetrically arranged; a rotary drum is rotationally connected into the tank body; a hollow shaft is fixedly connected to the bottom center of the drum; a separation cylinder is arranged in each rotating cylinder; limiting blocks which are symmetrically arranged are fixedly connected to the outer side of the separating cylinder; limiting grooves are formed in the positions, corresponding to the limiting blocks, of the side wall of the rotary drum. After a medical worker uses the separating cylinder to receive amniotic fluid and blood mixed liquid flowing out of a puerpera, the amniotic fluid and blood mixed liquid is placed in the rotating cylinder, the motor is used for driving the rotating cylinder to rotate, then the mixed liquid is centrifuged in the rotating cylinder under the cooperation of the rotating cylinder, the separating cylinder and the curved plate, and the sliding rod can be operated after standing for a little time; according to the scheme, blood is discharged into the container, then medical staff can know the condition of the puerpera by observing the blood in real time, and guarantee is provided for life safety of the puerpera.

The utility model relates to the technical field of medical auxiliary instruments, in particular to an empty needle auxiliary suction device for amniotic fluid puncture, which comprises a support arm, a connecting seat and a drawing mechanism, the connecting seat is arranged at the free end of the support arm, and the drawing mechanism is arranged at the bottom of the connecting seat; the drawing mechanism comprises a fixed body and a movable body which are oppositely arranged, a mounting cavity is formed in the fixed body, a suction assembly is arranged in the mounting cavity, and the suction assembly is connected with a piston rod of the injector and used for upwards drawing the piston rod; the opposite side walls of the fixed body and the movable body are each provided with a clamping groove used for being connected with a lug plate on the upper portion of an injector barrel. The movable body is arranged on the connecting base in a sliding mode, an elastic piece is further arranged on the connecting base, and the elastic piece is connected with the movable body and used for pushing the movable body to move in the direction of the fixed body. The fixing device can solve the technical problems that an existing fixing device is inconvenient to disassemble and assemble an injector quickly and cannot be suitable for injectors of different specifications.

The utility model discloses an amniotic cavity constant-speed perfusion device which effectively solves the problem that an existing amniotic cavity perfusion tool cannot conduct constant-speed perfusion. Comprising an up-down axial main body column, a left-right supporting rod is arranged at the upper end of the main body column, an up-down through sliding groove is formed in the supporting rod, a positioning shell is slidably connected into the sliding groove, an up-down axial up-down through needle placing hole is formed in the upper end of the positioning shell, and a puncture needle is detachably connected into the needle placing hole; an up-down axial containing groove is formed in the upper end of the main body column, a piston cylinder with a downward opening is coaxially arranged in the containing groove, a piston plate capable of moving up and down is coaxially arranged in the piston cylinder, and the upper end of the piston cylinder is connected with the upper end of the puncture needle through a hose; the amniotic cavity puncture infusion device can achieve puncture infusion of an amniotic cavity of a patient, relieve the phenomenon that the amniotic fluid of the patient is too little, keep constant-speed uniform infusion in the whole infusion process, and prevent the situation that the infusion speed is too high or too low, and consequently the patient is hurt.

Provided is a product that enables easy monitoring of early rupture of membranes and relates to a wearing article provided with a test strip using immunochromatography, wherein the test strip is designed to detect amniotic fluid-derived insulin-like growth factor binding protein 1 in vaginal secretion, and wherein, when the test strip detects 0.3-25 mg / L of insulin-like growth factor binding protein 1, the result is considered positive.

The present invention relates to methods and compositions for the treatment of spinal cord injury, to the use of amniotic fluid from non-human animals, in particular poultry and non-human mammals. The composition provided by the invention can be a cell culture medium containing the amniotic fluid and can also be a pharmaceutical composition.

The described invention provides compositions and methods for wound healing in a subject. The methods include administering a therapeutic amount of a pharmaceutical composition comprising extracellular vesicles from amniotic fluid and a pharmaceutically acceptable carrier.

A composition for treating a patient with a tissue disease or malformity has a composition containing amniotic fluid. The amniotic fluid has a quantity of gender specific amniotic fluid based on a gender of a fetal source. A method of treating a patient with a tissue disease or malformity comprises the steps of: identifying the tissue region to be treated and selecting a location to apply either topically or by injection or inhalation a composition containing amniotic fluid; selecting the composition containing amniotic fluid wherein the amniotic fluid has a quantity of gender specific amniotic fluid based on a gender of a fetal source allowing more specific targeted growth factors to be used for specific disease processes; and applying or injecting the composition at or into the selected location.

This invention proposes an intelligent labor management method and system that integrates LP (labor delivery) detection and multi-parameter monitoring. It belongs to the interdisciplinary fields of smart obstetrics, multimodal physiological monitoring, and human factors engineering. The method includes: dividing the labor process of primiparous women into multimodal monitoring areas, generating core obstetric parameter monitoring areas, and collecting psychological stress monitoring data via millimeter-wave radar and continuously monitoring the fetal biochemical environment via amniotic fluid biochemical probes; deploying the LP labor detection system, non-contact psychological sensors, and amniotic fluid biochemical probes based on these areas to construct an intelligent monitoring layout network; by integrating LP labor detection and multi-parameter monitoring, the overall efficiency of labor management is significantly improved: it achieves accurate monitoring of traditional parameters such as cervical dilation and fetal heart rate, and expands the holistic perception of key dimensions such as maternal psychological stress and amniotic fluid biochemical environment, greatly improving the completeness and real-time performance of labor monitoring.

The delivery device comprises a delivery bag and a liquid collecting device, the delivery bag comprises a bottom pad, a surrounding wall, a delivery outlet and a foot tube, the surrounding wall is arranged along the periphery of the bottom pad in a surrounding mode and used for preventing amniotic fluid and blood from flowing out, the surrounding wall is divided into a side plate and a tail plate, and the liquid outlet is formed in the tail plate; the enclosure bulkhead is made of a flexible material with an air bag, and the air bag expands and rises after being inflated, so that the enclosure bulkhead is vertically erected to prevent liquid from overflowing; the liquid collecting device comprises a liquid storage bag and a hose, and the liquid outlet, the hose and the liquid storage bag are sequentially connected. Amniotic fluid generated during delivery of a puerpera is collected, all body fluid is located on the bottom pad and the fluid storage bag, the body fluid is prevented from overflowing to the ground of a delivery room, a midwife and a delivery doctor are prevented from being exposed in the risk of body fluid infection, and meanwhile subsequent cleaning and killing work of the delivery room is reduced.

The utility model discloses an amniotic fluid puncture needle extension device for gynaecology and obstetrics examination, which relates to the technical field of gynaecology and obstetrics examination and comprises a puncture needle, an equipment clamping mechanism is mounted outside the puncture needle, and an equipment fixing mechanism is mounted below the equipment clamping mechanism. According to the amniotic fluid puncture needle extending device for gynaecology and obstetrics examination, a clamping ring is arranged outside a puncture needle, a limiting ring and a clamping inner ring are arranged in the middle of the clamping ring, when the puncture needle is inserted into the middle of the clamping inner ring in a penetrating mode, the clamping ring is held by a hand, springs are connected among the clamping ring, the limiting ring and the clamping inner ring, one end of each spring is stressed, and the clamping ring is inserted into the clamping inner ring. The clamping ring and the clamping inner ring gather towards the outside of the puncture needle, so that the puncture needles with different thicknesses and sizes are clamped, the limiting ring can limit the clamping inner ring and prevent the clamping inner ring from rebounding outwards, the outside of the puncture needle can be clamped through the design, and the puncture needle is prevented from falling off.

Provided is a composition including stem cell is derived from amniotic fluid of an artiodactyl animal. Also provided relates to uses of the composition for skin rejuvenation, skin treatment. promoting hair growth, and preventing hair loss, including administering an effective amount of the composition to the subject in need thereof.

The invention relates to an in-utero ventriculoamniotic shunting device that includes a composite shunt tube composed of polymer material, e.g., silicone-based material, and metallic wire, having a bend or curve formed in the length of the shunt tube, with one or more anchors composed of super-elastic wire or mesh, e.g., shape memory alloy wire or mesh structures, attached to the shunt tube, and a one-way passive valve composed of a thin polymer membrane. The anchors are effective to prevent migration and dislodgement of the shunting device following its deployment, and the valve is effective to prevent the backflow of amniotic fluid.

The invention relates to the field of hyperbaric oxygen therapy, in particular to an effect on body rehabilitation therapy in a gravity-free diving state in a closed high-pressure liquid environment. The hyperbaric oxygen zero-gravity rehabilitation treatment cabin comprehensively adopts the most advanced technology to restore the optimal environment state of hyperbaric oxygen rehabilitation treatment. A main cabin of the equipment is of a totally-closed structure, and the main cabin is filled with rehabilitation liquid containing different solutes. The main cabin is provided with a circulating breathing system, a constant temperature system and an emergency decompression system, and a relay liquid storage tank and a pressurization system are arranged outside the main cabin. After the main chamber is sealed and pressurized, the circulating breathing system can supply high-pressure oxygen air, and continuous supply and monitoring of high-pressure oxygen breathing under different pressures are achieved. Rehabilitation personnel in the main cabin gradually enter a weightlessness suspension state. The hyperbaric oxygen zero-gravity rehabilitation treatment cabin simulates and realizes an amniotic fluid-like environment. The conditions of temperature, pressure, gravity, aerobic regeneration of body tissues and the like of a fetus in an amniotic fluid state are represented to a certain extent.